Composition of Certain Financial Statement Captions (Details) - USD ($) $ in Thousands		Jun. 30, 2015	Dec. 31, 2014
Accounts receivable, net
Accounts receivable		$ 29,045	$ 21,875
Less: allowance for doubtful accounts		(2,065)	(1,906)
Accounts receivable, net	[1]	26,980	19,969
Inventories, net
Finished products		13,830	12,116
Work in-process		1,619	1,011
Raw materials		5,782	4,116
Less: inventory reserve		(712)	(639)
Inventory, net	[1]	20,519	16,604
Prepaid expenses and other current assets
Prepaid supplies		1,441	1,123
Prepaid insurance		613	968
Other receivables		1,107	669
Taxes recoverable		3,074	2,417
Other		3,388	4,212
Prepaid expenses and other current assets	[1]	9,623	9,389
Intangible assets, net:
Less: accumulated amortization		(38,798)	(33,931)
Intangible assets, net	[1]	94,247	62,649
Accrued expenses:
Taxes payable		2,592	77
Deferred revenue		75,159	4,185
Clinical trials		8,534	8,643
Professional fees		1,724	1,860
Employee benefits		5,456	4,127
Contingent consideration		41,146	27,352
Other		15,232	14,668
Accrued expenses	[1]	149,843	60,912
Other long-term liabilities:
Mortgages and other debts payable		2,148	2,434
Deferred tax liabilities		172,458	167,153
Deferred revenue		197,279	2,526
Other		3,753	1,030
Other long-term liabilities	[1]	408,821	217,358
OPKO Renal
Other long-term liabilities:
Contingent consideration		19,183	36,529
OPKO Health Europe
Other long-term liabilities:
Contingent consideration		225	254
Mortgages and other debts payable		2,393	2,435
OPKO Diagnostics
Other long-term liabilities:
Contingent consideration		13,342	6,992
CURNA
Other long-term liabilities:
Contingent consideration		433	440
Technologies
Intangible assets, net:
Intangible assets		52,287	52,508
Customer relationships
Intangible assets, net:
Intangible assets		55,750	22,108
Product registrations
Intangible assets, net:
Intangible assets		8,088	8,763
Trade names
Intangible assets, net:
Intangible assets		3,411	3,483
Covenants not to compete
Intangible assets, net:
Intangible assets		8,620	8,639
Other
Intangible assets, net:
Intangible assets		$ 4,889	$ 1,079

[1] As of June 30, 2015 and December 31, 2014, total assets include $7.1 million and $7.6 million, respectively, and total liabilities include $12.7 million and $12.1 million, respectively, related to SciVac Ltd (“SciVac”), now known as SciVac Therapeutics, Inc., a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 5.